No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ABT240705C105000
- 0.48
- -0.33-40.74%
15min DelayClose Jun 28 16:00 ET
1.27High0.44Low
1.27Open0.81Pre Close104 Volume102 Open Interest105.00Strike Price6.19KTurnover18.54%IV1.51%PremiumJul 5, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.48Extrinsic Value100Contract SizeAmericanOptions Type0.3309Delta0.1609Gamma214.25Leverage Ratio-0.0900Theta0.0046Rho70.90Eff Leverage0.0440Vega
Intraday
- 5D
- Daily
News
Rising Drug Costs Force a Third of Americans to Leave Prescriptions Unfilled: Report
Did Your Heart Skip a Beat? Your Wearable Knows. -- Barrons.com
Express News | FDA Says Abbott Medical Issues Correction For HeartMate LVAS System Monitor Due To Screen Issues That Could Cause Unintentional Pump Stop
Express News | FDA: Abbott Heartmate Lvas System Monitor Recall Involves Correcting Devices & Does Not Involve Removing Them From Where They Are Used or Sold
Express News | FDA: There Have Been 14 Reported Injuries, No Reports of Death Related to Recall
Express News | FDA: Abbott Medical Issues Correction for Heartmate Lvas System Monitor Due to Screen Issues That May Cause Unintentional Pump Stop
Comments
Morning Movers
Gapping up
$United Airlines(UAL.US$ stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel.
$Abbott Laboratories(ABT.US$ stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...
Gapping up
$United Airlines(UAL.US$ stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel.
$Abbott Laboratories(ABT.US$ stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...
30
$Abbott Laboratories(ABT.US$
Introduction
On April 17th, before the US stock market opened, Abbott (NYSE: ABT) will hold a conference call to announce its financial results for the first quarter of 2024. As a global leader in healthcare, Abbott's performance has been steadily improving in recent years, especially benefiting from the COVID-19 pandemic. According to Bloomberg data, the follow...
Introduction
On April 17th, before the US stock market opened, Abbott (NYSE: ABT) will hold a conference call to announce its financial results for the first quarter of 2024. As a global leader in healthcare, Abbott's performance has been steadily improving in recent years, especially benefiting from the COVID-19 pandemic. According to Bloomberg data, the follow...
1
$Abbott Laboratories(ABT.US$ Hmmm. As usual, red again
Insiders selling shares with no recorded purchases over the last year could worry investors. Despite high insider ownership, recent selling activity suggests insiders don't see shares as a bargain.
The 4- and 5-star rated Dividend Aristocrats for 2024 include Abbott Laboratories, AbbVie Inc., Air Products & Chemicals, and others such as Coca-Cola Co., McDonald's Corp., Walmart Inc., and West Pharmaceuticals.
1
Read more